Nucleoside diphosphate kinase/Nm23 and Epstein-Barr virus

Molecular and Cellular Biochemistry

Volumn 329, Issue 1-2, 2009, Pages 131-139

  Murakami, Masanao ^a   Kaul, Rajeev ^a   Kumar, Pankaj ^a   Robertson, Erle S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Epstein Barr virus; NDPK and cell migration; Nm23 H1

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN; EPSTEIN BARR VIRUS ANTIGEN 1; EPSTEIN BARR VIRUS ANTIGEN 3C; NUCLEOSIDE DIPHOSPHATE KINASE A; NUCLEOSIDE DIPHOSPHATE KINASE NM23; PROTEIN P27; UNCLASSIFIED DRUG; EBNA 3C, EPSTEIN BARR VIRUS; EBNA-3C, EPSTEIN-BARR VIRUS; EBV ENCODED NUCLEAR ANTIGEN 1; EBV-ENCODED NUCLEAR ANTIGEN 1; VIRUS ANTIGEN;

APOPTOSIS; B LYMPHOCYTE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL MIGRATION; CELL PROLIFERATION; CELL TRANSFORMATION; EPSTEIN BARR VIRUS; GENE EXPRESSION; GENOMIC IN SITU HYBRIDIZATION; IMMUNE DEFICIENCY; NONHUMAN; PROMOTER REGION; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TRANSACTIVATION; VIRUS REACTIVATION; BIOLOGICAL MODEL; CELL MOTION; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; VIRUS INFECTION;

HUMAN HERPESVIRUS 4; MAMMALIA;

ANTIGENS, VIRAL; CELL MOVEMENT; CELL PROLIFERATION; EPSTEIN-BARR VIRUS INFECTIONS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HERPESVIRUS 4, HUMAN; HUMANS; MODELS, BIOLOGICAL; NM23 NUCLEOSIDE DIPHOSPHATE KINASES;

EID: 70449732874     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-009-0123-4     Document Type: Review

References (120)

1. B Titus MA Schwartz D Theodorescu 2005 Rho proteins in cell migration and metastasis Crit Rev Eukaryot Gene Expr 15 103 114 10.1615/ CritRevEukaryotGeneExpr.v15.i2.20 16022631 1:CAS:528:DC%2BD2MXpsFWrsLs%3D 10.1615/CritRevEukaryotGeneExpr.v15.i2.20 (Pubitemid 41277406)
2. PS Steeg 2004 Perspectives on classic article: metastasis suppressor genes J Natl Cancer Inst 96 E4 15026478
3. ML Lacombe L Milon A Munier JG Mehus DO Lambeth 2000 The human Nm23/nucleoside diphosphate kinases J Bioenerg Biomembr 32 247 258 10.1023/A:1005584929050 11768308 1:CAS:528:DC%2BD3cXms1yhu74%3D 10.1023/A:1005584929050 (Pubitemid 30727489)
4. RL Russell AN Pedersen J Kantor K Geisinger R Long N Zbieranski A Townsend B Shelton N Brunner TE Kute 1998 Relationship of nm23 to proteolytic factors, proliferation and motility in breast cancer tissues and cell lines Br J Cancer 78 710 717 9743288 1:CAS:528:DyaK1cXmsVKnu70%3D
5. YT Tee GD Chen LY Lin JL Ko PH Wang 2006 Nm23-H1: a metastasis-associated gene Taiwan J Obstet Gynecol 45 107 113 17197349 10.1016/S1028-4559(09)60206-0
6. Kieff E, Rickinson AB (2002) Epstein-Barr virus and its replication. In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (eds) Fundamental virology. Lippincott Williams and Wilkins, Philadelphia
7. D Burkitt 1958 A sarcoma involving the jaws in African children Br J Surg 46 218 223 10.1002/bjs.18004619704 13628987 1:STN:280:DyaG1M%2FlvVGkuw%3D%3D 10.1002/bjs.18004619704
8. MA Epstein BG Achong YM Barr 1964 Virus particles in cultured lymphoblasts from Burkitt's lymphoma Lancet 1 702 703 10.1016/S0140-6736(64) 91524-7 14107961 1:STN:280:DyaF2c%2FmsFKmtw%3D%3D 10.1016/S0140-6736(64)91524-7
9. G Henle W Henle V Diehl 1968 Relation of Burkitt's tumor-associated herpes-type virus to infectious mononucleosis Proc Natl Acad Sci USA 59 94 101 10.1073/pnas.59.1.94 5242134 1:STN:280:DyaF1czitVKqtg%3D%3D 10.1073/pnas.59.1.94
10. H zur Hausen H Schulte-Holthausen G Klein W Henle G Henle P Clifford L Santesson 1970 EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx Nature 228 1056 1058 10.1038/2281056a0 4320657 1:CAS:528:DyaE3MXltFGqtQ%3D%3D 10.1038/2281056a0
11. RP Hasserjian NL Harris 2007 NK-cell lymphomas and leukemias: a spectrum of tumors with variable manifestations and immunophenotype Am J Clin Pathol 127 860 868 10.1309/2F39NX1AL3L54WU8 17509983 1:CAS:528:DC%2BD2sXntVCntb8%3D 10.1309/2F39NX1AL3L54WU8
12. JW Said T Tasaka S Takeuchi H Asou S de Vos E Cesarman DM Knowles HP Koeffler 1996 Primary effusion lymphoma in women: report of two cases of Kaposi's sarcoma herpes virus-associated effusion-based lymphoma in human immunodeficiency virus-negative women Blood 88 3124 3128 8874212 1:CAS:528:DyaK28XmtlWjtbc%3D
13. B Johansson G Klein W Henle G Henle 1970 Epstein-Barr virus (EBV)-associated antibody patterns in malignant lymphoma and leukemia. I. Hodgkin's disease Int J Cancer 6 450 462 10.1002/ijc.2910060316 4321018 1:STN:280:DyaE3M%2FlsFylug%3D%3D 10.1002/ijc.2910060316
14. DT Purtilo JP Yang S Allegra D DeFlorio LM Hutt M Soltani G Vawter 1977 Hematopathology and pathogenesis of the X-linked recessive lymphoproliferative syndrome Am J Med 62 225 233 10.1016/0002-9343(77)90318-7 835602 1:STN:280:DyaE2s7gvFWjug%3D%3D 10.1016/0002-9343(77)90318-7 (Pubitemid 8042837)
15. RS Bar CJ DeLor KP Clausen P Hurtubise W Henle JF Hewetson 1974 Fatal infectious mononucleosis in a family N Engl J Med 290 363 367 4358992 1:STN:280:DyaE2c%2FotVKisQ%3D%3D
16. C Alfieri M Birkenbach E Kieff 1991 Early events in Epstein-Barr virus infection of human B lymphocytes Virology 181 595 608 10.1016/0042-6822(91) 90893-G 1849678 1:CAS:528:DyaK3MXhs1ahurw%3D 10.1016/0042-6822(91)90893-G
17. MA Lee ME Diamond JL Yates 1999 Genetic evidence that EBNA-1 is needed for efficient, stable latent infection by Epstein-Barr virus J Virol 73 2974 2982 10074147 1:CAS:528:DyaK1MXhvFyntr0%3D
18. JL Yates SM Camiolo JM Bashaw 2000 The minimal replicator of Epstein-Barr virus oriP J Virol 74 4512 4522 10.1128/JVI.74.10.4512-4522.2000 10775587 1:CAS:528:DC%2BD3cXivFygtbY%3D 10.1128/JVI.74.10.4512-4522.2000 (Pubitemid 30237876)
19. GJ Inman PJ Farrell 1995 Epstein-Barr virus EBNA-LP and transcription regulation properties of pRB, p107 and p53 in transfection assays J Gen Virol 76 Pt 9 2141 2149 10.1099/0022-1317-76-9-2141 7561751 1:CAS:528:DyaK2MXnvVyqurY%3D 10.1099/0022-1317-76-9-2141
20. JI Cohen F Wang J Mannick E Kieff 1989 Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation Proc Natl Acad Sci USA 86 9558 9562 10.1073/pnas.86.23.9558 2556717 1:CAS:528:DyaK3cXps1aqsA%3D%3D 10.1073/pnas.86.23.9558 (Pubitemid 20010466)
21. W Hammerschmidt B Sugden 1989 Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes Nature 340 393 397 10.1038/340393a0 2547164 1:CAS:528:DyaL1MXltV2qs7w%3D 10.1038/340393a0 (Pubitemid 19191606)
22. KM Kaye KM Izumi E Kieff 1993 Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation Proc Natl Acad Sci USA 90 9150 9154 10.1073/pnas.90.19.9150 8415670 1:CAS:528:DyaK3sXmt1ejt7Y%3D 10.1073/pnas.90.19.9150 (Pubitemid 23306469)
23. B Tomkinson E Robertson E Kieff 1993 Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation J Virol 67 2014 2025 8445720 1:CAS:528:DyaK3sXisFagtbY%3D (Pubitemid 23088375)
24. SL Silins TB Sculley 1995 Burkitt's lymphoma cells are resistant to programmed cell death in the presence of the Epstein-Barr virus latent antigen EBNA-4 Int J Cancer 60 65 72 10.1002/ijc.2910600110 7814154 1:STN:280: DyaK2M7htlGktw%3D%3D 10.1002/ijc.2910600110
25. S Fruehling R Longnecker 1997 The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction Virology 235 241 251 10.1006/viro.1997.8690 9281504 1:CAS:528:DyaK2sXmt1ahurk%3D 10.1006/viro.1997.8690 (Pubitemid 27394337)
26. AB Rickinson DJ Moss 1997 Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection Annu Rev Immunol 15 405 431 10.1146/annurev. immunol.15.1.405 9143694 1:CAS:528:DyaK2sXisVCmtrc%3D 10.1146/annurev.immunol. 15.1.405 (Pubitemid 27169287)
27. S Maruo E Johannsen D Illanes A Cooper B Zhao E Kieff 2005 Epstein-Barr virus nuclear protein 3A domains essential for growth of lymphoblasts: transcriptional regulation through RBP-Jkappa/CBF1 is critical J Virol 79 10171 10179 10.1128/JVI.79.16.10171-10179.2005 16051810 1:CAS:528:DC%2BD2MXntFCrtLk%3D 10.1128/JVI.79.16.10171-10179.2005 (Pubitemid 41098558)
28. U Zimber-Strobl LJ Strobl 2001 EBNA2 and Notch signalling in Epstein-Barr virus mediated immortalization of B lymphocytes Semin Cancer Biol 11 423 434 10.1006/scbi.2001.0409 11669604 1:CAS:528:DC%2BD3MXns1ylurc%3D 10.1006/scbi.2001.0409 (Pubitemid 33105021)
29. A Le Roux B Kerdiles D Walls JF Dedieu M Perricaudet 1994 The Epstein-Barr virus determined nuclear antigens EBNA-3A, -3B, and -3C repress EBNA-2-mediated transactivation of the viral terminal protein 1 gene promoter Virology 205 596 602 10.1006/viro.1994.1687 7975264 1:CAS:528:DyaK2MXit12qu70%3D 10.1006/viro.1994.1687 (Pubitemid 24371708)
30. D Marshall C Sample 1995 Epstein-Barr virus nuclear antigen 3C is a transcriptional regulator J Virol 69 3624 3630 7745710 1:CAS:528: DyaK2MXls1yitbw%3D
31. N Kienzle D Young SL Silins TB Sculley 1996 Induction of pleckstrin by the Epstein-Barr virus nuclear antigen 3 family Virology 224 167 174 10.1006/viro.1996.0518 8862411 1:CAS:528:DyaK28XmsVSkurs%3D 10.1006/viro.1996. 0518 (Pubitemid 26358112)
32. ES Robertson T Ooka ED Kieff 1996 Epstein-Barr virus vectors for gene delivery to B lymphocytes Proc Natl Acad Sci USA 93 11334 11340 10.1073/pnas.93.21.11334 8876136 1:CAS:528:DyaK28Xmtlagsr4%3D 10.1073/pnas.93.21.11334 (Pubitemid 26347122)
33. C Subramanian ES Robertson 2002 The metastatic suppressor Nm23-H1 interacts with EBNA3C at sequences located between the glutamine- and proline-rich domains and can cooperate in activation of transcription J Virol 76 8702 8709 10.1128/JVI.76.17.8702-8709.2002 12163590 1:CAS:528: DC%2BD38Xmt1erur0%3D 10.1128/JVI.76.17.8702-8709.2002 (Pubitemid 34864065)
34. B Zhao CE Sample 2000 Epstein-Barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein-Barr virus nuclear antigen 2 through sequences encompassing an spi-1/Spi-B binding site J Virol 74 5151 5160 10.1128/JVI.74.11.5151-5160.2000 10799590 1:CAS:528:DC%2BD3cXjsVKgu7k%3D 10.1128/JVI.74.11.5151-5160.2000 (Pubitemid 30313855)
35. JS Knight K Lan C Subramanian ES Robertson 2003 Epstein-Barr virus nuclear antigen 3C recruits histone deacetylase activity and associates with the corepressors mSin3A and NCoR in human B-cell lines J Virol 77 4261 4272 10.1128/JVI.77.7.4261-4272.2003 12634383 1:CAS:528:DC%2BD3sXisVKrs7g%3D 10.1128/JVI.77.7.4261-4272.2003 (Pubitemid 36350964)
36. R Touitou M Hickabottom G Parker T Crook MJ Allday 2001 Physical and functional interactions between the corepressor CtBP and the Epstein-Barr virus nuclear antigen EBNA3C J Virol 75 7749 7755 10.1128/JVI.75.16.7749-7755.2001 11462050 1:CAS:528:DC%2BD3MXlsFKrs7Y%3D 10.1128/JVI.75.16.7749-7755.2001 (Pubitemid 32738036)
37. PS Steeg G Bevilacqua L Kopper UP Thorgeirsson JE Talmadge LA Liotta ME Sobel 1988 Evidence for a novel gene associated with low tumor metastatic potential J Natl Cancer Inst 80 200 204 10.1093/jnci/80.3.200 3346912 1:CAS:528:DyaL1cXktVWltLg%3D 10.1093/jnci/80.3.200
38. VP Pinon G Millot A Munier J Vassy G Linares-Cruz J Capeau F Calvo ML Lacombe 1999 Cytoskeletal association of the A and B nucleoside diphosphate kinases of interphasic but not mitotic human carcinoma cell lines: specific nuclear localization of the B subunit Exp Cell Res 246 355 367 10.1006/excr.1998.4318 9925751 1:CAS:528:DyaK1MXpsFaktg%3D%3D 10.1006/excr.1998.4318 (Pubitemid 29393998)
39. R Hirayama S Sawai Y Takagi Y Mishima N Kimura N Shimada Y Esaki C Kurashima M Utsuyama K Hirokawa 1991 Positive relationship between expression of anti-metastatic factor (nm23 gene product or nucleoside diphosphate kinase) and good prognosis in human breast cancer J Natl Cancer Inst 83 1249 1250 10.1093/jnci/83.17.1249 1651398 1:STN:280:DyaK3Mzjt12nsA%3D%3D 10.1093/jnci/83.17.1249
40. JA Royds TJ Stephenson RC Rees AJ Shorthouse PB Silcocks 1993 Nm23 protein expression in ductal in situ and invasive human breast carcinoma J Natl Cancer Inst 85 727 731 10.1093/jnci/85.9.727 8386774 1:STN:280: DyaK3s3ktVGlsw%3D%3D 10.1093/jnci/85.9.727
41. MT Hartsough PS Steeg 2000 Nm23/nucleoside diphosphate kinase in human cancers J Bioenerg Biomembr 32 301 308 10.1023/A:1005597231776 11768314 1:CAS:528:DC%2BD3cXms1yhu7g%3D 10.1023/A:1005597231776 (Pubitemid 30727495)
42. N Niitsu M Okamoto J Okabe-Kado T Takagi T Yoshida S Aoki Y Honma M Hirano 2001 Serum nm23-H1 protein as a prognostic factor for indolent non-Hodgkin's lymphoma Leukemia 15 832 839 10.1038/sj.leu.2402105 11368446 1:CAS:528:DC%2BD3MXks1KksL0%3D 10.1038/sj.leu.2402105 (Pubitemid 32492708)
43. N Hailat DR Keim RF Melhem XX Zhu C Eckerskorn GM Brodeur CP Reynolds RC Seeger F Lottspeich JR Strahler, et al. 1991 High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification J Clin Invest 88 341 345 10.1172/JCI115299 2056128 1:STN:280:DyaK3M3nslejsA%3D%3D 10.1172/JCI115299
44. A Leone RC Seeger CM Hong YY Hu MJ Arboleda GM Brodeur D Stram DJ Slamon PS Steeg 1993 Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas Oncogene 8 855 865 8384356 1:CAS:528:DyaK3sXisFagurs%3D
45. S Nakamori O Ishikawa H Ohhigashi M Kameyama H Furukawa Y Sasaki H Inaji M Higashiyama S Imaoka T Iwanaga, et al. 1993 Expression of nucleoside diphosphate kinase/nm23 gene product in human pancreatic cancer: an association with lymph node metastasis and tumor invasion Clin Exp Metastasis 11 151 158 10.1007/BF00114973 8383029 1:STN:280:DyaK3s7osFeltg%3D%3D 10.1007/BF00114973
46. Y Oda T Naka M Takeshita Y Iwamoto M Tsuneyoshi 2000 Comparison of histological changes and changes in nm23 and c-MET expression between primary and metastatic sites in osteosarcoma: a clinicopathologic and immunohistochemical study Hum Pathol 31 709 716 10.1053/hupa.2000.8230 10872665 1:STN:280:DC%2BD3czivFSltA%3D%3D 10.1053/hupa.2000.8230
47. SK Kraeft F Traincart S Mesnildrey J Bourdais M Veron LB Chen 1996 Nuclear localization of nucleoside diphosphate kinase type B (nm23-H2) in cultured cells Exp Cell Res 227 63 69 10.1006/excr.1996.0250 8806452 1:CAS:528:DyaK28XltlymtLk%3D 10.1006/excr.1996.0250 (Pubitemid 26293416)
48. EH Postel SJ Berberich SJ Flint CA Ferrone 1993 Human c-myc transcription factor PuF identified as nm23-H2 nucleoside diphosphate kinase, a candidate suppressor of tumor metastasis Science 261 478 480 10.1126/science.8392752 8392752 1:CAS:528:DyaK3sXmsVagt74%3D 10.1126/science.8392752
49. SJ Berberich EH Postel 1995 PuF/NM23-H2/NDPK-B transactivates a human c-myc promoter-CAT gene via a functional nuclease hypersensitive element Oncogene 10 2343 2347 7784082 1:CAS:528:DyaK2MXmsFCgsLk%3D
50. F Agou S Raveh S Mesnildrey M Veron 1999 Single strand DNA specificity analysis of human nucleoside diphosphate kinase B J Biol Chem 274 19630 19638 10.1074/jbc.274.28.19630 10391900 1:CAS:528:DyaK1MXksFKmt78%3D 10.1074/jbc.274.28.19630 (Pubitemid 29327738)
51. S Raveh J Vinh J Rossier F Agou M Veron 2001 Peptidic determinants and structural model of human NDP kinase B (Nm23-H2) bound to single-stranded DNA Biochemistry 40 5882 5893 10.1021/bi001085j 11352723 1:CAS:528: DC%2BD3MXivFCjs74%3D 10.1021/bi001085j (Pubitemid 32466290)
52. SJ Cho NS Lee YS Jung H Lee KJ Lee E Kim SK Chae 2001 Identification of structural domains affecting transactivation potential of Nm23 Biochem Biophys Res Commun 289 738 743 10.1006/bbrc.2001.6042 11726210 1:CAS:528: DC%2BD3MXos1amsbY%3D 10.1006/bbrc.2001.6042 (Pubitemid 33152295)
53. C Subramanian MA Cotter II ES Robertson 2001 Epstein-Barr virus nuclear protein EBNA-3C interacts with the human metastatic suppressor Nm23-H1: a molecular link to cancer metastasis Nat Med 7 350 355 10.1038/85499 11231635 1:CAS:528:DC%2BD3MXhvVOktro%3D 10.1038/85499 (Pubitemid 32224352)
54. GL Kelly AE Milner GS Baldwin AI Bell AB Rickinson 2006 Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells Proc Natl Acad Sci USA 103 14935 14940 10.1073/pnas.0509988103 17001014 1:CAS:528:DC%2BD28XhtVygsrbI 10.1073/pnas.0509988103 (Pubitemid 44527832)
55. M Murakami K Lan C Subramanian ES Robertson 2005 Epstein-Barr virus nuclear antigen 1 interacts with Nm23-H1 in lymphoblastoid cell lines and inhibits its ability to suppress cell migration J Virol 79 1559 1568 10.1128/JVI.79.3.1559-1568.2005 15650182 1:CAS:528:DC%2BD2MXhtFCjtLg%3D 10.1128/JVI.79.3.1559-1568.2005 (Pubitemid 40459103)
56. PD Wagner ND Vu 2000 Phosphorylation of geranyl and farnesyl pyrophosphates by Nm23 proteins/nucleoside diphosphate kinases J Biol Chem 275 35570 35576 10.1074/jbc.M006106200 10952986 1:CAS:528:DC%2BD3cXotFehsr8%3D 10.1074/jbc.M006106200 (Pubitemid 30832584)
57. PD Wagner ND Vu 2000 Histidine to aspartate phosphotransferase activity of nm23 proteins: phosphorylation of aldolase C on Asp-319 Biochem J 346 Pt 3 623 630 10.1042/0264-6021:3460623 10698688 1:CAS:528:DC%2BD3cXit1Kku7c%3D 10.1042/0264-6021:3460623 (Pubitemid 30171022)
58. MT Hartsough DK Morrison M Salerno D Palmieri T Ouatas M Mair J Patrick PS Steeg 2002 Nm23-H1 metastasis suppressor phosphorylation of kinase suppressor of Ras via a histidine protein kinase pathway J Biol Chem 277 32389 32399 10.1074/jbc.M203115200 12105213 1:CAS:528:DC%2BD38Xmslyjtr4%3D 10.1074/jbc.M203115200 (Pubitemid 34969057)
59. EK Flemington 2001 Herpesvirus lytic replication and the cell cycle: arresting new developments J Virol 75 4475 4481 10.1128/JVI.75.10.4475-4481.2001 11312317 1:CAS:528:DC%2BD3MXjt1OlsLc%3D 10.1128/JVI.75.10.4475-4481.2001 (Pubitemid 32381489)
60. GA Parker T Crook M Bain EA Sara PJ Farrell MJ Allday 1996 Epstein-Barr virus nuclear antigen (EBNA)3C is an immortalizing oncoprotein with similar properties to adenovirus E1A and papillomavirus E7 Oncogene 13 2541 2549 9000128 1:CAS:528:DyaK2sXotFKjtA%3D%3D
61. S Maruo Y Wu S Ishikawa T Kanda D Iwakiri K Takada 2006 Epstein-Barr virus nuclear protein EBNA3C is required for cell cycle progression and growth maintenance of lymphoblastoid cells Proc Natl Acad Sci USA 103 19500 19505 10.1073/pnas.0604919104 17159137 1:CAS:528:DC%2BD2sXhs1yqsg%3D%3D 10.1073/pnas.0604919104 (Pubitemid 46026060)
62. JS Knight N Sharma ES Robertson 2005 Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase Proc Natl Acad Sci USA 102 18562 18566 10.1073/pnas.0503886102 16352731 1:CAS:528:DC%2BD28Xpt1Oq 10.1073/pnas. 0503886102 (Pubitemid 43011265)
63. JS Knight N Sharma ES Robertson 2005 SCFSkp2 complex targeted by Epstein-Barr virus essential nuclear antigen Mol Cell Biol 25 1749 1763 10.1128/MCB.25.5.1749-1763.2005 15713632 1:CAS:528:DC%2BD2MXhvFOhuro%3D 10.1128/MCB.25.5.1749-1763.2005 (Pubitemid 40280142)
64. GA Parker R Touitou MJ Allday 2000 Epstein-Barr virus EBNA3C can disrupt multiple cell cycle checkpoints and induce nuclear division divorced from cytokinesis Oncogene 19 700 709 10.1038/sj.onc.1203327 10698515 1:CAS:528:DC%2BD3cXhsVOgu7g%3D 10.1038/sj.onc.1203327
65. V Andres 2004 Control of vascular cell proliferation and migration by cyclin-dependent kinase signalling: new perspectives and therapeutic potential Cardiovasc Res 63 11 21 10.1016/j.cardiores.2004.02.009 15194457 1:CAS:528:DC%2BD2cXkvV2it74%3D 10.1016/j.cardiores.2004.02.009 (Pubitemid 38759805)
66. JS Knight ES Robertson 2004 Epstein-Barr virus nuclear antigen 3C regulates cyclin A/p27 complexes and enhances cyclin A-dependent kinase activity J Virol 78 1981 1991 10.1128/JVI.78.4.1981-1991.2004 14747563 1:CAS:528:DC%2BD2cXhtFKns70%3D 10.1128/JVI.78.4.1981-1991.2004 (Pubitemid 38176730)
67. JS Knight N Sharma DE Kalman ES Robertson 2004 A cyclin-binding motif within the amino-terminal homology domain of EBNA3C binds cyclin A and modulates cyclin A-dependent kinase activity in Epstein-Barr virus-infected cells J Virol 78 12857 12867 10.1128/JVI.78.23.12857-12867.2004 15542638 1:CAS:528: DC%2BD2cXhtVaqtbjM 10.1128/JVI.78.23.12857-12867.2004 (Pubitemid 39507794)
68. KG Krauer A Burgess M Buck J Flanagan TB Sculley B Gabrielli 2004 The EBNA-3 gene family proteins disrupt the G2/M checkpoint Oncogene 23 1342 1353 10.1038/sj.onc.1207253 14716295 1:CAS:528:DC%2BD2cXhtlKhtbc%3D 10.1038/sj.onc.1207253 (Pubitemid 38406830)
69. T Choudhuri SC Verma K Lan M Murakami ES Robertson 2007 The ATM/ATR signaling effector Chk2 is targeted by Epstein-Barr virus nuclear antigen 3C to release the G2/M cell cycle block J Virol 81 6718 6730 10.1128/JVI.00053-07 17409144 1:CAS:528:DC%2BD2sXmt1Ort7o%3D 10.1128/JVI.00053-07 (Pubitemid 46878076)
70. H Jung HA Seong H Ha 2007 NM23-H1 tumor suppressor and its interacting partner STRAP activate p53 function J Biol Chem 282 35293 35307 10.1074/jbc.M705181200 17916563 1:CAS:528:DC%2BD2sXhtlCrtLzK 10.1074/jbc.M705181200 (Pubitemid 350232484)
71. DA Kuppers K Lan JS Knight ES Robertson 2005 Regulation of matrix metalloproteinase 9 expression by Epstein-Barr virus nuclear antigen 3C and the suppressor of metastasis Nm23-H1 J Virol 79 9714 9724 10.1128/JVI.79.15.9714- 9724.2005 16014933 1:CAS:528:DC%2BD2MXmvVels7w%3D 10.1128/JVI.79.15.9714-9724. 2005 (Pubitemid 41022314)
72. T Choudhuri SC Verma K Lan ES Robertson 2006 Expression of alpha V integrin is modulated by Epstein-Barr virus nuclear antigen 3C and the metastasis suppressor Nm23-H1 through interaction with the GATA-1 and Sp1 transcription factors Virology 351 58 72 10.1016/j.virol.2006.03.031 16631833 1:CAS:528:DC%2BD28XntVyru7Y%3D 10.1016/j.virol.2006.03.031 (Pubitemid 44041081)
73. I Stamenkovic 2000 Matrix metalloproteinases in tumor invasion and metastasis Semin Cancer Biol 10 415 433 10.1006/scbi.2000.0379 11170864 1:CAS:528:DC%2BD3MXhtVGhu74%3D 10.1006/scbi.2000.0379 (Pubitemid 32181912)
74. J Westermarck VM Kahari 1999 Regulation of matrix metalloproteinase expression in tumor invasion FASEB J 13 781 792 10224222 1:CAS:528: DyaK1MXjtFGksrs%3D
75. EI Deryugina JP Quigley 2006 Matrix metalloproteinases and tumor metastasis Cancer Metastasis Rev 25 9 34 10.1007/s10555-006-7886-9 16680569 1:CAS:528:DC%2BD28Xktlaksr4%3D 10.1007/s10555-006-7886-9 (Pubitemid 43723979)
76. JA Nemeth MT Nakada M Trikha Z Lang MS Gordon GC Jayson R Corringham U Prabhakar HM Davis RA Beckman 2007 Alpha-v integrins as therapeutic targets in oncology Cancer Invest 25 632 646 10.1080/07357900701522638 18027153 1:CAS:528:DC%2BD2sXhtlWku7nJ 10.1080/07357900701522638 (Pubitemid 350135743)
77. S Huang D Stupack A Liu D Cheresh GR Nemerow 2000 Cell growth and matrix invasion of EBV-immortalized human B lymphocytes is regulated by expression of alpha(v) integrins Oncogene 19 1915 1923 10.1038/sj.onc.1203509 10773881 1:CAS:528:DC%2BD3cXjtV2qu78%3D 10.1038/sj.onc.1203509
78. C Trocme P Gaudin S Berthier C Barro P Zaoui F Morel 1998 Human B lymphocytes synthesize the 92-kDa gelatinase, matrix metalloproteinase-9 J Biol Chem 273 20677 20684 10.1074/jbc.273.32.20677 9685427 1:CAS:528: DyaK1cXlsVWnsrk%3D 10.1074/jbc.273.32.20677 (Pubitemid 28377640)
79. T Yoshizaki H Sato M Furukawa JS Pagano 1998 The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1 Proc Natl Acad Sci USA 95 3621 3626 10.1073/pnas.95.7.3621 9520415 1:CAS:528:DyaK1cXitlKjsbw%3D 10.1073/pnas.95.7.3621 (Pubitemid 28173177)
80. D Lombardi 2006 Commentary: nm23, a metastasis suppressor gene with a tumor suppressor gene aptitude? J Bioenerg Biomembr 38 177 180 10.1007/s10863-006-9032-3 16944303 1:CAS:528:DC%2BD28XhtlShsL3P 10.1007/s10863-006-9032-3 (Pubitemid 44946225)
81. PS Steeg T Ouatas D Halverson D Palmieri M Salerno 2003 Metastasis suppressor genes: basic biology and potential clinical use Clin Breast Cancer 4 51 62 10.3816/CBC.2003.n.012 12744759 1:CAS:528:DC%2BD3sXlslOgtb0%3D 10.3816/CBC.2003.n.012
82. R Kaul SC Verma M Murakami K Lan T Choudhuri ES Robertson 2006 Epstein-Barr virus protein can upregulate cyclo-oxygenase-2 expression through association with the suppressor of metastasis Nm23-H1 J Virol 80 1321 1331 10.1128/JVI.80.3.1321-1331.2006 16415009 1:CAS:528:DC%2BD28XpvVWgtQ%3D%3D 10.1128/JVI.80.3.1321-1331.2006 (Pubitemid 43134089)
83. YH Tseng D Vicent J Zhu Y Niu A Adeyinka JS Moyers PH Watson CR Kahn 2001 Regulation of growth and tumorigenicity of breast cancer cells by the low molecular weight GTPase Rad and nm23 Cancer Res 61 2071 2079 11280768 1:CAS:528:DC%2BD3MXit1OgsL0%3D
84. M Engel OG Issinger I Lascu T Seib S Dooley KD Zang C Welter 1994 Phosphorylation of nm23/nucleoside diphosphate kinase by casein kinase 2 in vitro Biochem Biophys Res Commun 199 1041 1048 10.1006/bbrc.1994.1334 8135777 1:CAS:528:DyaK2cXivFaksL0%3D 10.1006/bbrc.1994.1334 (Pubitemid 24181767)
85. RM Biondi M Engel M Sauane C Welter OG Issinger L Jimenez de Asua S Passeron 1996 Inhibition of nucleoside diphosphate kinase activity by in vitro phosphorylation by protein kinase CK2. Differential phosphorylation of NDP kinases in HeLa cells in culture FEBS Lett 399 183 187 10.1016/S0014-5793(96) 01299-9 8980148 1:CAS:528:DyaK28XntlOju78%3D 10.1016/S0014-5793(96)01299-9 (Pubitemid 27007981)
86. L Garzia A D'Angelo A Amoresano SK Knauer C Cirulli C Campanella RH Stauber C Steegborn A Iolascon M Zollo 2008 Phosphorylation of nm23-H1 by CKI induces its complex formation with h-prune and promotes cell motility Oncogene 27 1853 1864 10.1038/sj.onc.1210822 17906697 1:CAS:528:DC%2BD1cXjsFChtb0%3D 10.1038/sj.onc.1210822
87. N Marino M Zollo 2007 Understanding h-prune biology in the fight against cancer Clin Exp Metastasis 24 637 645 10.1007/s10585-007-9109-3 17952613 1:CAS:528:DC%2BD1cXhvFGgtr0%3D 10.1007/s10585-007-9109-3 (Pubitemid 350159737)
88. A D'Angelo L Garzia A Andre P Carotenuto V Aglio O Guardiola G Arrigoni A Cossu G Palmieri L Aravind M Zollo 2004 Prune cAMP phosphodiesterase binds nm23-H1 and promotes cancer metastasis Cancer Cell 5 137 149 10.1016/S1535-6108(04)00021-2 14998490 10.1016/S1535-6108(04)00021-2 (Pubitemid 38283800)
89. Z Fan PJ Beresford DY Oh D Zhang J Lieberman 2003 Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor Cell 112 659 672 10.1016/S0092-8674(03)00150-8 12628186 1:CAS:528:DC%2BD3sXitFykurc%3D 10.1016/S0092-8674(03)00150-8 (Pubitemid 36331778)
90. GW Bornkamm W Hammerschmidt 2001 Molecular virology of Epstein-Barr virus Philos Trans R Soc Lond B Biol Sci 356 437 459 10.1098/rstb.2000.0781 11313004 1:CAS:528:DC%2BD3MXltFWgtr4%3D 10.1098/rstb.2000.0781
91. S Murono H Inoue T Tanabe I Joab T Yoshizaki M Furukawa JS Pagano 2001 Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells Proc Natl Acad Sci USA 98 6905 6910 10.1073/pnas.121016998 11381123 1:CAS:528:DC%2BD3MXksVOrs7Y%3D 10.1073/pnas.121016998 (Pubitemid 32538315)
92. H Sano Y Kawahito RL Wilder A Hashiramoto S Mukai K Asai S Kimura H Kato M Kondo T Hla 1995 Expression of cyclooxygenase-1 and -2 in human colorectal cancer Cancer Res 55 3785 3789 7641194 1:CAS:528:DyaK2MXnvVelsbg%3D
93. H Wolff K Saukkonen S Anttila A Karjalainen H Vainio A Ristimaki 1998 Expression of cyclooxygenase-2 in human lung carcinoma Cancer Res 58 4997 5001 9823297 1:CAS:528:DyaK1cXnsFSmsbs%3D
94. D Hwang D Scollard J Byrne E Levine 1998 Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer J Natl Cancer Inst 90 455 460 10.1093/jnci/90.6.455 9521170 1:STN:280:DyaK1c7otVCltw%3D%3D 10.1093/jnci/90.6.455
95. A Ristimaki N Honkanen H Jankala P Sipponen M Harkonen 1997 Expression of cyclooxygenase-2 in human gastric carcinoma Cancer Res 57 1276 1280 9102213 1:CAS:528:DyaK2sXit1Oju7c%3D
96. KC Zimmermann M Sarbia AA Weber F Borchard HE Gabbert K Schror 1999 Cyclooxygenase-2 expression in human esophageal carcinoma Cancer Res 59 198 204 9892207 1:CAS:528:DyaK1MXms1ejsg%3D%3D
97. DW Tang SC Lin KW Chang CW Chi CS Chang TY Liu 2003 Elevated expression of cyclooxygenase (COX)-2 in oral squamous cell carcinoma-evidence for COX-2 induction by areca quid ingredients in oral keratinocytes J Oral Pathol Med 32 522 529 10.1034/j.1600-0714.2003.00182.x 12969226 1:CAS:528:DC%2BD3sXos1Wmsr0%3D 10.1034/j.1600-0714.2003.00182.x (Pubitemid 37175004)
98. H Sheng J Shao SC Kirkland P Isakson RJ Coffey J Morrow RD Beauchamp RN DuBois 1997 Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2 J Clin Invest 99 2254 2259 10.1172/JCI119400 9151799 1:CAS:528:DyaK2sXjtFCitrc%3D 10.1172/JCI119400
99. N Rioux A Castonguay 1998 Prevention of NNK-induced lung tumorigenesis in A/J mice by acetylsalicylic acid and NS-398 Cancer Res 58 5354 5360 9850065 1:CAS:528:DyaK1cXotVSktLw%3D
100. BS Reddy 2000 The fourth DeWitt S. Goodman lecture. Novel approaches to the prevention of colon cancer by nutritional manipulation and chemoprevention Cancer Epidemiol Biomarkers Prev 9 239 247 10750661 1:CAS:528: DC%2BD3cXisVKntLc%3D
101. H Sawaoka S Kawano S Tsuji M Tsujii ES Gunawan Y Takei K Nagano M Hori 1998 Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice Am J Physiol 274 G1061 G1067 9696706 1:CAS:528:DyaK1cXktVCrsLs%3D
102. MA Molina M Sitja-Arnau MG Lemoine ML Frazier FA Sinicrope 1999 Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs Cancer Res 59 4356 4362 10485483 1:CAS:528:DyaK1MXlvVSmsLw%3D
103. JP Peng HC Chang CF Hwang WC Hung 2005 Overexpression of cyclooxygenase-2 in nasopharyngeal carcinoma and association with lymph node metastasis Oral Oncol 41 903 908 10.1016/j.oraloncology.2005.05.003 16054423 1:CAS:528:DC%2BD2MXpvFektrk%3D 10.1016/j.oraloncology.2005.05.003 (Pubitemid 41265949)
104. WL Smith DL DeWitt RM Garavito 2000 Cyclooxygenases: structural, cellular, and molecular biology Annu Rev Biochem 69 145 182 10.1146/annurev. biochem.69.1.145 10966456 1:CAS:528:DC%2BD3cXnt1ajtLg%3D 10.1146/annurev. biochem.69.1.145 (Pubitemid 30792207)
105. WL Smith RM Garavito DL DeWitt 1996 Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2 J Biol Chem 271 33157 33160 10.1074/jbc.271.52.33157 8969167 1:CAS:528:DyaK2sXitFaksg%3D%3D 10.1074/jbc.271.52.33157 (Pubitemid 27010118)
106. P Needleman J Turk BA Jakschik AR Morrison JB Lefkowith 1986 Arachidonic acid metabolism Annu Rev Biochem 55 69 102 10.1146/annurev.bi.55.070186.000441 3017195 1:CAS:528:DyaL28XltFaru7g%3D 10.1146/annurev.bi.55.070186.000441
107. HR Herschman 1996 Prostaglandin synthase 2 Biochim Biophys Acta 1299 125 140 8555245
108. GN Levy 1997 Prostaglandin H synthases, nonsteroidal anti-inflammatory drugs, and colon cancer FASEB J 11 234 247 9068612 1:CAS:528:DyaK2sXhvVGls70%3D
109. N Ray ME Bisher LW Enquist 2004 Cyclooxygenase-1 and -2 are required for production of infectious pseudorabies virus J Virol 78 12964 12974 10.1128/JVI.78.23.12964-12974.2004 15542648 1:CAS:528:DC%2BD2cXhtVaqtbnM 10.1128/JVI.78.23.12964-12974.2004 (Pubitemid 39507804)
110. SG Hansen LI Strelow DC Franchi DG Anders SW Wong 2003 Complete sequence and genomic analysis of rhesus cytomegalovirus J Virol 77 6620 6636 10.1128/JVI.77.12.6620-6636.2003 12767982 1:CAS:528:DC%2BD3sXksFGitb4%3D 10.1128/JVI.77.12.6620-6636.2003 (Pubitemid 36666856)
111. TL Symensma D Martinez-Guzman Q Jia E Bortz TT Wu N Rudra-Ganguly S Cole H Herschman R Sun 2003 COX-2 induction during murine gammaherpesvirus 68 infection leads to enhancement of viral gene expression J Virol 77 12753 12763 10.1128/JVI.77.23.12753-12763.2003 14610197 1:CAS:528:DC%2BD3sXptFOjsL8%3D 10.1128/JVI.77.23.12753-12763.2003 (Pubitemid 37430670)
112. N Sharma-Walia H Raghu S Sadagopan R Sivakumar MV Veettil PP Naranatt MM Smith B Chandran 2006 Cyclooxygenase 2 induced by Kaposi's sarcoma-associated herpesvirus early during in vitro infection of target cells plays a role in the maintenance of latent viral gene expression J Virol 80 6534 6552 10.1128/JVI.00231-06 16775340 1:CAS:528:DC%2BD28XntFWis7k%3D 10.1128/JVI.00231-06 (Pubitemid 43927455)
113. S Narumiya Y Sugimoto F Ushikubi 1999 Prostanoid receptors: structures, properties, and functions Physiol Rev 79 1193 1226 10508233 1:CAS:528: DyaK1MXmvVymtL0%3D
114. J Ye L Gradoville D Daigle G Miller 2007 De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists J Virol 81 9279 9291 10.1128/JVI.00982-07 17596302 1:CAS:528:DC%2BD2sXps1amtro%3D 10.1128/JVI.00982-07 (Pubitemid 47311470)
115. BM Gebhardt ED Varnell HE Kaufman 2005 Inhibition of cyclooxygenase 2 synthesis suppresses Herpes simplex virus type 1 reactivation J Ocul Pharmacol Ther 21 114 120 10.1089/jop.2005.21.114 15857277 1:CAS:528:DC%2BD2MXjsVeqsb8%3D 10.1089/jop.2005.21.114 (Pubitemid 40577966)
116. J Askling L Klareskog P Blomqvist M Fored N Feltelius 2006 Risk for malignant lymphoma in ankylosing spondylitis: a nationwide Swedish case-control study Ann Rheum Dis 65 1184 1187 10.1136/ard.2005.047514 16414970 1:STN:280:DC%2BD28vnvFKrsA%3D%3D 10.1136/ard.2005.047514 (Pubitemid 44277393)
117. F Wolfe K Michaud 2004 Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18, 572 patients Arthritis Rheum 50 1740 1751 10.1002/art.20311 15188349 1:CAS:528: DC%2BD2cXlsFaqt7Y%3D 10.1002/art.20311 (Pubitemid 38725085)
118. M Murakami PI Meneses JS Knight K Lan R Kaul SC Verma ES Robertson 2008 Nm23-H1 modulates the activity of the guanine exchange factor Dbl-1 Int J Cancer 123 500 510 18470881 1:CAS:528:DC%2BD1cXotVyhsLo%3D 10.1002/ijc.23568 (Pubitemid 351898406)
119. M Murakami PI Meneses JS Knight K Lan R Kaul SC Verma ES Robertson 2008 The suppressor of metastasis Nm23-H1 interacts with the Cdc42 Rho family member and the pleckstrin homology domain of oncoprotein Dbl-1 to suppress cell migration Cancer Biol Ther 7 679 690 10.1158/1535-7163.MCT-07-0450 10.1158/1535-7163.MCT-07-0450 1:CAS:528:DC%2BD1cXjtlWgsrY%3D
120. AM Mileo E Piombino A Severino A Tritarelli MG Paggi D Lombardi 2006 Multiple interference of the human papillomavirus-16 E7 oncoprotein with the functional role of the metastasis suppressor Nm23-H1 protein J Bioenerg Biomembr 38 215 225 10.1007/s10863-006-9037-y 17103045 1:CAS:528:DC%2BD28XhtlShsLrK 10.1007/s10863-006-9037-y (Pubitemid 44946229)